Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | Director | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,217,579 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Gift · Disposed 19,400 · Balance 5,217,579 F1: These shares were gifted to individuals who do not share the Reporting Person's household. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 339,233 |
Reported balance
After 2026-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-01 · Grant · Acquired 52,023 · Balance 339,233 F2: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person. |
| Common StockSEC Table I · non-derivative | Indirectby The Modified 2009 WTS Irrev Trust Dated 12/16/22 | 1,606,842 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,606,842 |
| Common StockSEC Table I · non-derivative | IndirectWAC LLC | 481,721 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 481,721 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.99 · Expires 2029-02-28 | Direct | 78,750 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 78,750 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.93 · Expires 2030-02-28 | Direct | 112,500 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 112,500 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.81 · Expires 2031-02-28 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 90,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2032-02-29 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 90,000 |
| Stock Units (SU)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 35,609.301 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 35,609.301 F3: These stock units were accrued under the Issuer's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's director cash compensation and are settled in shares of the Issuer's common stock on a one-for-one basis on the last business day of the calendar quarter following Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were gifted to individuals who do not share the Reporting Person's household.
F2: These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.
F3: These stock units were accrued under the Issuer's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's director cash compensation and are settled in shares of the Issuer's common stock on a one-for-one basis on the last business day of the calendar quarter following Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PRAXAIR INC
Report date October 31, 2018 · Filed November 01, 2018
Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 1
1 source rowRow 1 · 2018-10-31 · Disposition to issuer · Disposed 21,058.88 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-10-31 · Disposition to issuer · Disposed 2,915.04 · Balance 0 F2: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-10-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-10-31 · Disposition to issuer · Disposed 31,630.276 · Balance 0 F3: Conversion to Praxair Common Stock is on a 1-for-1 basis. F4: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F5: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
F2: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
F3: Conversion to Praxair Common Stock is on a 1-for-1 basis.
F4: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.
F5: This total includes shares previously acquired through automatic dividend reinvestment under the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2019 Filed May 7, 2019 21:45 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | PurchaseCommon Stock | 491,472 | $3.43 | $1,685,748.96 |
DisclosureSEC source: 0001209191-19-028031 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451,038 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/6/2019 at prices ranging from $3.29 to $3.50, inclusive. Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:45 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | PurchaseCommon Stock | 323,084 | $3.32 | $1,072,315.80 |
DisclosureSEC source: 0001209191-19-028031 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959,566 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/3/2019 at prices ranging from $3.225 to $3.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 78,750 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001209191-19-015613 · doc4.xml · derivative · entry 6 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2029-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 157,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015613 · doc4.xml · derivative · entry 5 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,500 Underlying: Common Stock · 157,500 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 40% to a Cumulative Same-Store Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 43,286 | $4.99 | $215,997.14 |
DisclosureSEC source: 0001209191-19-015613 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,636,482 Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 78,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015613 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,679,768 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 17:08 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerDeferred Stock Units · Derivative | 31,630.276 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000073 · edgar.xml · derivative · entry 3 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,630.276 shares Expires not disclosed F3 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F4 · derivative.exercise_date: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F4 · derivative.expiration_date: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan. In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F5 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 17:08 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerRestricted Stock Units · Derivative | 2,915.04 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000073 · edgar.xml · derivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,915.04 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F2 · derivative.exercise_date: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Units ("RSUs") that have vested in full but whose payout was deferred. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 17:08 UTC | PRAXAIR INC PX · Entity 162268 | Disposition to issuerCommon Stock | 21,058.88 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000073 · edgar.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F1 · price: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCAt") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. In connection with the BCA, Praxair, Inc. became an indiect wholly-owned subsidiary of Linde plc, and each share of Praxair Common stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 18:17 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 148.042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000066 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,630.276 Underlying: Common Stock · 148.042 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 18:41 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 157.947 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000055 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,315.158 Underlying: Common Stock · 157.947 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 18:01 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000032 · edgar.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,430.052 F1 · shares: Restricted stock unit award, vesting 100% and payable in shares of Praxair Common Stock one year after April 24, 2018 if the awardee is serving on the Praxair, Inc. Board of Directors on that vesting date, unless termination of service occurs in connection with certain events, in which case the grant will vest in full. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:24 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 175.932 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000025 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,997.639 Underlying: Common Stock · 175.932 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:36 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 105,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015681 · doc4.xml · derivative · entry 5 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2028-02-28 F2 · derivative.exercise_date: The vesting of 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The vesting of the remaining 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Margin Improvement for the 2018-2020 Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Adjusted EBITDA Margin Improvement criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:36 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 49,188 | $4.58 | $225,281.04 |
DisclosureSEC source: 0001209191-18-015681 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601,018 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:36 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 105,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015681 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650,206 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:41 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 160.061 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-18-000004 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,659.224 Underlying: Common Stock · 160.061 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:09 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 177.066 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000068 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,339.455 Underlying: Common Stock · 177.066 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 20:25 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 186.316 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000062 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,986.452 Underlying: Common Stock · 186.316 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| April 25, 2017 Filed Apr 27, 2017 20:47 UTC | PRAXAIR INC PX · Entity 162268 | GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000036 · edgar.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,153.735 F1 · shares: Restricted stock unit award, vesting 100% and payable in shares of Praxair Common Stock one year after April 25, 2017 if the awardee is serving on the Praxair, Inc. Board of Directors on that vesting date, unless termination of service occurs in connection with certain events, in which case the grant will vest in full. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 19:19 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 211.864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000025 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,627.132 Underlying: Common Stock · 211.864 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 75,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016576 · doc4.xml · derivative · entry 7 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-02-28 F3 · derivative.exercise_date: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016576 · doc4.xml · derivative · entry 6 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 104,875 | $9.19 | $963,801.25 |
DisclosureSEC source: 0001209191-17-016576 · doc4.xml · nonDerivative · entry 3 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,206 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016576 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:23 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016576 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,081 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:29 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 213.857 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-17-000004 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,221.273 Underlying: Common Stock · 213.857 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 21:14 UTC | PRAXAIR INC PX · Entity 162268 | GrantDeferred Stock Units · Derivative | 206.202 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000884905-16-000177 · edgar.xml · derivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,832.223 Underlying: Common Stock · 206.202 shares Expires not disclosed F1 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F2 · derivative.exercise_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F2 · derivative.expiration_date: Deferred stock units acquired by reporting person under the Praxair, Inc. Director's Fees Deferral Plan and are to be settled in Praxair Common Stock upon the reporting person's retirement or termination of service. F3 · balance_after: This total includes shares previously acquired through automatic dividend reinvestment under the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.